Navigation Links
Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles

. Solomon, F. Chan, M. Zhao, S. Cosenza, M. Reddy, M. Rudek, P. Kulecza, E. P. Reddy and M. Hidalgo (abstract 5391).

About Onconova's Product-Pipeline

Onconova is developing several novel product candidates directed at critical kinase targets involved in the regulation of signal transduction, cell-cycle and DNA repair. These candidates are derived from the Company's proprietary library of new chemical entities and non-ATP competitive chemotypes. In addition to ON 01910.Na, Onconova is also developing Ex-RAD(TM), an injectable and oral radioprotectant, and inhibitors of JAK and Bcr-abl pathways.

About Onconova Therapeutics, Inc.

Onconova, based in Lawrenceville, NJ, discovers and develops novel therapeutic agents for cancer, radiation protection and hematological disorders. Currently, the Company is conducting clinical trials at major centers in the USA and abroad. The novel chemical library platform is permitting identification of non-ATP competitive kinase inhibitors directed at validated and novel targets, and a new immunoconjugate technology for arming monoclonal antibodies for cancer therapy. All of the Company's products and technologies are being developed internally.

For further information on Onconova Therapeutics, Inc., please visit http://www.onconova.com.

All trademarks are registered to their respective owners.

Contact

Investors
Onconova Therapeutics, Inc.
Dr. Ramesh Kumar
President and CEO
609-844-7735
or
Media
KMorrisPR
Kathryn Morris
845-635-9828
kathryn@kmorrispr.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:9/18/2014)... , Sept. 18, 2014   Fruit Street Health ... an initial seed round of funding. ... led by a series of individual investors, the majority ... participated in the initial round are; Houston Cardiology ... Center Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... BURLINGTON, Mass. , Sept. 18, 2014  Decision ... launched anti-vascular endothelial growth factor (VEGF) agent for wet ... and Medicare Advantage plans as Genentech,s Lucentis, which is ... although surveyed managed care organization (MCO) directors do not ... Eylea is slightly more likely than Lucentis to be ...
(Date:9/18/2014)... , Sept. 18, 2014  A $3 million grant ... the University of Michigan to establish a national center ... Glenn Center for Aging Research at U-M will focus ... can slow the effects of aging and postpone diseases ... aging that can help develop medications that may help ...
Breaking Medicine Technology:Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3
... April 25, 2011 The ophthalmic therapeutics company Xcovery ... and CEO, and Dr. Ken Mandell, President and COO, ... Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale ... of a Serial Entrepreneur recounts his repeated success ...
... April 25, 2011 The 2010 Pharmacy Today ... American Pharmacists Association , reveals pharmacists believe that ... was recommended by their pharmacist, 92% of pharmacists walk ... a product selection and the average patient consult takes ...
Cached Medicine Technology:Xcovery Vision Founders to Speak at ARVO 2011 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 3
(Date:9/18/2014)... "Medical staff need better ways to provide quick ... privacy," said one of two inventors from Hialeah, Fla. ... supply caregivers with the equipment they need to do ... The Helper to make it easier to reposition a ... his or her side. It also securely stabilizes the ...
(Date:9/18/2014)... 2014 It’s been just a few short ... pending bunion splint to website visitors, but already the response ... was absolutely delighted. It is perfect and I find it ... them. THANK YOU FOR LISTENING!!!" Another user compared the ... hole used to slip to the end of my toe. ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Companies in ... refine carbon dioxide, selling it to downstream industries in ... for carbon dioxide are food and beverage manufacturers. Food ... as fruits, vegetables or pizzas. The gas is also ... use the compound to carbonate soft drinks, beer and ...
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, ... waiting times, patients seeking care at larger urban hospitals are ... those seen at smaller or more rural facilities, new research ... provide timely emergency care varies dramatically across hospitals in the ... research, Dr. Renee Hsia, an associate professor at the University ...
(Date:9/18/2014)... Sept. 18, 2014 (HealthDay News) -- Daily supplements of ... against the development of age-related cataracts among men, a ... that one or both could help prevent cataracts. To ... Hospital and Harvard Medical School in Boston, and his ... selenium and vitamin E. The trial was initially designed ...
Breaking Medicine News(10 mins):Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2
... MONDAY, Oct. 17 (HealthDay News) -- For years, nutritionists ... eat." Now, new research suggests this adage might even ... observation stems from a pair of studies slated for presentation ... in Orlando, Fla., both of which highlight an apparent linkage ...
... MASS. October 17, 2011 The Institute for ... announced Sharon K. Inouye, M.D., M.P.H., has been elected ... independent, nonprofit organization that works outside of government to ... the public. Inouye is the Director of the ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) ... candy and some medications, teachers are almost as likely to ... by two enterprising elementary schoolers. Casey Gittelman, who,s ... a special medicine cabinet filled with medicine and candies to ...
... is available in French and Spanish . ... than other women. Furthermore, the likelihood of developing breast cancer is ... of the main conclusions drawn in an article recently published in ... Granada research group CTS 367, coordinated by the Nursery Department professor ...
... Jenifer Goodwin HealthDay Reporter , SATURDAY, Oct. 15 ... hospital emergency departments don,t believe their weight poses a risk ... them otherwise, a new study finds. Researchers asked 450 ... at Shands at the University of Florida two questions: Do ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) -- Is ... so, says a new study that finds a link between ... However, the research doesn,t confirm that exposure to trash-talking ... explain why non-aggressive cussing might be a bad thing. And ...
Cached Medicine News:Health News:Healthier Diet, Stronger Sperm? 2Health News:Healthier Diet, Stronger Sperm? 3Health News:Hebrew SeniorLife's Dr. Sharon K. Inouye elected to Institute of Medicine 2Health News:It's Easy to Mistake Medicine for Candy 2Health News:It's Easy to Mistake Medicine for Candy 3Health News:Obese women have higher risk of suffering breast cancer 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 3Health News:Many Don't Believe Their Obesity is Unhealthy: Study 4Health News:Profanity on TV Linked to Foul-Mouthed Kids 2
... for Candida albicans in only five ... two enzyme color reactions to produce ... read. AlbiQuicktm is performed on a ... Incubation time is only five minutes ...
... for small and large multi-specialty provider networks. ... check-out. Review the complete Patient History, from ... labs and charts all by one click ... immediately. Communicate electronically with the referring physicians ...
... meridianEMR is a revolutionary "blended model EMR ... medical records in your office and on-line ... of physicians and software engineers, meridianEMR combines ... create a highly modular medical EMR that ...
... an Automated Digital Cell Morphology and Informatics ... and transmission of White & Red Blood ... blood smears can be loaded at once, ... 60 per hour depending on the tests ...
Medicine Products: